IP Library Granted Patent US 7,141,554
Granted Patent B2
US 7,141,554 · App. 10/942,722 · Granted Nov 28, 2006

Method of treating irritable bowel syndrome

View Patent ↗
Loading inventors, assignments & file history…
Monitor This Case
Get email alerts when status or documents change.
Order Certified Copies
Most orders are placed with the USPTO same day — all within 24 business hours.
Order via The Patent Place →
Pre-filled with this patent's details
Quick Facts
Patent No.
US 7,141,554
App. No.
10/942,722
Granted
Nov 28, 2006
Kind
B2
Abstract

A nutritional composition is disclosed which comprises synergistic functional carbohydrates for preventing or treating infection by pathogenic bacteria and/or promoting gut flora balance and health. The carbohydrates have a synergistic activity on promoting bifidobacteria in the intestine. Also disclosed are a method of production of the composition; and a method of treatment of infection by pathogenic bacteria and/or promoting gut flora balance and health which comprises administering an effective amount of the composition.

Claims (17)

1. A method of treating Irritable Bowel Syndrome (IBS) in a patient in need of such treatment, which comprises administering thereto a nutritional composition comprising at least two synergistic functional carbohydrates, wherein a first carbohydrate is inulin or fructooligosaccharide (FOS) and a second carbohydrate is xylooligosaccharide (XOS), acacia gum or resistant starch, with the carbohydrates being present in amounts effective to stimulate intestinal bifidobacteria, and the composition being administered in an amount effective to treat IBS by providing increased amounts of intestinal bifidobacteria.

2. A method according to claim 1 , wherein the first carbohydrate of the nutritional composition comprises inulin and the second carbohydrate comprises an xylooligosaccharide.

3. A method according to claim 1 , wherein the first carbohydrate of the nutritional composition comprises inulin and the second carbohydrate comprises acacia gum.

4. A method according to claim 1 , wherein the first carbohydrate comprises fructooligosaccharide and the second carbohydrate comprises an xylooligosaccharide.

5. A method according to claim 1 , wherein the first carbohydrate comprises fructooligosaccharide and the second carbohydrate comprises acacia gum.

6. A method according to claim 1 , wherein the first and the second carbohydrates are present in the composition in a weight ratio of 1–20:0.1–20.

7. A method according to claim 1 , wherein the nutritional composition is combined with a food, food-forming, beverage, or beverage-forming component to formulate an edible composition that is administered to the patient.

8. A method according to claim 7 , wherein the edible composition is in the form of a powder or liquid concentrate.

9. A method according to claim 7 , wherein the first carbohydrate is present in an amount of about 1 g to about 20 g and the second carbohydrate is present in an amount of about 0.1 g to about 20 g.

10. A method according to claim 7 , wherein the first and the second carbohydrates are present in a weight ratio of 1–20:0.1–20.

11. A method according to claim 7 , wherein the edible composition further comprises a fat source that provides about 5% to about 55% of the energy of the edible composition.

12. A method according to claim 11 , wherein the fat source is a vegetable fat or animal fat.

13. A method according to claim 7 , wherein the edible composition further comprises one or more of a protein source, a fat source, an additional carbohydrate source, an additional dietary fiber, a vitamin, a mineral or a food grade emulsifier.

14. A method according to claim 7 , wherein the edible composition further contains milk.

15. A method according to claim 1 , wherein the composition is administered in an amount sufficient to treat an infection by pathogenic bacteria.

16. A method according to claim 1 , wherein the composition is administered in an amount sufficient to promote gut flora balance and health in the patient.

17. A method according to claim 1 , wherein the composition is administered in an amount sufficient to reduce side effects of consuming fiber by the patient.

Assignments (5)
CORRECTIVE ASSIGNMENT TO CORRECT THE PATENT NUMBER 16062921 PREVIOUSLY RECORDED ON REEL 049391 FRAME 0756. ASSIGNOR(S) HEREBY CONFIRMS THE PATENT NUMBER SHOULD HAVE BEEN 16062912. Recorded Jul 3, 2020
From: NESTEC S.A.
To: SOCIÉTÉ DES PRODUITS NESTLÉ S.A.
Reel/Frame 054082/0001 →
CORRECTIVE ASSIGNMENT TO CORRECT THE PATENT NUMBER 16062921 PREVIOUSLY RECORDED ON REEL 049391 FRAME 0756. ASSIGNOR(S) HEREBY CONFIRMS THE PATENT NUMBER SHOULD HAVE BEEN 16062912. Recorded Jul 3, 2020
From: NESTEC S.A.
To: SOCIÉTÉ DES PRODUITS NESTLÉ S.A.
Reel/Frame 054082/0165 →
CORRECTIVE ASSIGNMENT TO CORRECT THE ENGLISH TRANSLATION TO SHOW THE FULL AND CORRECT NEW NAME IN SECTION 51. PREVIOUSLY RECORDED AT REEL: 049391 FRAME: 0756. ASSIGNOR(S) HEREBY CONFIRMS THE MERGER. Recorded Jun 13, 2019
From: NESTEC S.A.
To: SOCIÉTÉ DES PRODUITS NESTLÉ S.A.
Reel/Frame 049853/0398 →
MERGER Recorded Jun 6, 2019
From: NESTEC S.A.
To: SOCIÉTÉ DES PRODUITS NESTLÉ S.A.
Reel/Frame 049391/0756 →
ASSIGNMENT OF ASSIGNOR'S INTEREST Recorded Apr 25, 2005
From: ROCHAT, FLORENCE; BALLEVRE, OLIVIER; JANN, ALFRED
To: NESTEC S.A.
Reel/Frame 016151/0104 →